Epigenetic Explorations of Neurological Disorders, the Identification Methods, and Therapeutic Avenues
Open Access
- 30 October 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (21) , 11658
Abstract
Neurodegenerative disorders are major health concerns globally, especially in aging societies. The exploration of brain epigenomes, which consist of multiple forms of DNA methylation and covalent histone modifications, offers new and unanticipated perspective into the mechanisms of aging and neurodegenerative diseases. Initially, chromatin defects in the brain were thought to be static abnormalities from early development associated with rare genetic syndromes. However, it is now evident that mutations and the dysregulation of the epigenetic machinery extend across a broader spectrum, encompassing adult-onset neurodegenerative diseases. Hence, it is crucial to develop methodologies that can enhance epigenetic research. Several approaches have been created to investigate alterations in epigenetics on a spectrum of scales—ranging from low to high—with a particular focus on detecting DNA methylation and histone modifications. This article explores the burgeoning realm of neuroepigenetics, emphasizing its role in enhancing our mechanistic comprehension of neurodegenerative disorders and elucidating the predominant techniques employed for detecting modifications in the epigenome. Additionally, we ponder the potential influence of these advancements on shaping future therapeutic approaches.Keywords
Funding Information
- National Institutes of Health (R01 DK129241, DK126662)
This publication has 272 references indexed in Scilit:
- Ranking of Alzheimer's disease and related dementia among the leading causes of death in the US varies depending on NCHS or WHO definitionsAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023
- In situ Chromatin Interaction Analysis Using Paired‐End Tag SequencingCurrent Protocols, 2021
- Сlass II histone deacetylases in the post‐stroke recovery period—expression, cellular, and subcellular localization—promising targets for neuroprotectionJournal of Cellular Biochemistry, 2019
- Protective effects of ex‐527 on cerebral ischemia–reperfusion injury through necroptosis signaling pathway attenuationJournal of Cellular Physiology, 2018
- Age‐related changes in Egr1 transcription and DNA methylation within the hippocampusHippocampus, 2016
- Epigenomic Networking in Drug Development: From Pathogenic Mechanisms to PharmacogenomicsDrug Development Research, 2014
- Neuroprotective effects of resveratrol on damages of mouse cortical neurons induced by β‐amyloid through activation of SIRT1/Akt1 pathwayBioFactors, 2013
- Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's diseaseEMBO Molecular Medicine, 2012
- DNMT3B gene amplification predicts resistance to DNA demethylating drugsGenes, Chromosomes and Cancer, 2011
- Randomized sequential trial of valproic acid in amyotrophic lateral sclerosisAnnals of Neurology, 2009